For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Celanese Corp’s stock clocked out at $40.16, up 2.21% from its previous closing price of $39.29. In other words, the price has increased by $2.21 from its previous closing price. On the day, 1.34 million shares were traded. CE stock price reached its highest trading level at $41.36 during the session, while it also had its lowest trading level at $40.04.
Ratios:
To gain a deeper understanding of CE’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.75 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 6.96. For the most recent quarter (mrq), Quick Ratio is recorded 1.22 and its Current Ratio is at 2.05. In the meantime, Its Debt-to-Equity ratio is 2.52 whereas as Long-Term Debt/Eq ratio is at 2.46.
On June 16, 2025, Wells Fargo Upgraded its rating to Overweight which previously was Equal Weight but kept the price unchanged to $66.
BMO Capital Markets Upgraded its Underperform to Market Perform on May 20, 2025, while the target price for the stock was maintained at $55.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 08 ’25 when Go Timothy bought 1,039 shares for $46.25 per share. The transaction valued at 48,053 led to the insider holds 4,415 shares of the business.
Murray Mark Christopher bought 2,017 shares of CE for $84,371 on Aug 14 ’25. The SVP – Acetyls now owns 17,000 shares after completing the transaction at $41.83 per share. On Aug 14 ’25, another insider, Sutton Scott McDougald, who serves as the Director of the company, bought 2,000 shares for $40.89 each. As a result, the insider paid 81,787 and bolstered with 20,376 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CE now has a Market Capitalization of 4397669888 and an Enterprise Value of 16966669312. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.44 while its Price-to-Book (P/B) ratio in mrq is 0.83. Its current Enterprise Value per Revenue stands at 1.707 whereas that against EBITDA is 10.063.
Stock Price History:
The Beta on a monthly basis for CE is 1.18, which has changed by -0.6997832 over the last 52 weeks, in comparison to a change of 0.1443547 over the same period for the S&P500. Over the past 52 weeks, CE has reached a high of $137.36, while it has fallen to a 52-week low of $36.29. The 50-Day Moving Average of the stock is -10.18%, while the 200-Day Moving Average is calculated to be -25.29%.
Shares Statistics:
It appears that CE traded 2.13M shares on average per day over the past three months and 1675040 shares per day over the past ten days. A total of 109.50M shares are outstanding, with a floating share count of 108.98M. Insiders hold about 0.48% of the company’s shares, while institutions hold 108.56% stake in the company. Shares short for CE as of 1759190400 were 8395728 with a Short Ratio of 3.95, compared to 1756425600 on 6742703. Therefore, it implies a Short% of Shares Outstanding of 8395728 and a Short% of Float of 10.17.
Dividends & Splits
With its trailing 12-month dividend rate of 1.46, CE has a forward annual dividend rate of 0.79. Against a Trailing Annual Dividend Yield of 0.037159584. The stock’s 5-year Average Dividend Yield is 2.25.
Earnings Estimates
The firm’s stock currently is rated by 16.0 analysts. The consensus estimate for the next quarter is $1.05, with high estimates of $1.43 and low estimates of $0.81.
Analysts are recommending an EPS of between $4.62 and $4.02 for the fiscal current year, implying an average EPS of $4.31. EPS for the following year is $5.77, with 16.0 analysts recommending between $6.45 and $5.25.
Revenue Estimates
In. The current quarter, 12 analysts expect revenue to total $2.51B. It ranges from a high estimate of $2.56B to a low estimate of $2.47B. As of. The current estimate, Celanese Corp’s year-ago sales were $2.65BFor the next quarter, 12 analysts are estimating revenue of $2.34B. There is a high estimate of $2.42B for the next quarter, whereas the lowest estimate is $2.29B.
A total of 15 analysts have provided revenue estimates for CE’s current fiscal year. The highest revenue estimate was $9.9B, while the lowest revenue estimate was $9.37B, resulting in an average revenue estimate of $9.73B. In the same quarter a year ago, actual revenue was $10.28BBased on 15 analysts’ estimates, the company’s revenue will be $9.91B in the next fiscal year. The high estimate is $10.12B and the low estimate is $9.33B.
